Axonics Net Profit Margin 2017-2024 | AXNX
Axonics net profit margin from 2017 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Axonics Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-03-31 | $0.39B | $-0.02B | -3.88% |
| 2023-12-31 | $0.37B | $-0.01B | -1.36% |
| 2023-09-30 | $0.34B | $-0.01B | -3.21% |
| 2023-06-30 | $0.32B | $-0.03B | -9.69% |
| 2023-03-31 | $0.30B | $-0.05B | -15.20% |
| 2022-12-31 | $0.27B | $-0.06B | -21.61% |
| 2022-09-30 | $0.24B | $-0.08B | -31.25% |
| 2022-06-30 | $0.22B | $-0.08B | -35.02% |
| 2022-03-31 | $0.19B | $-0.08B | -41.24% |
| 2021-12-31 | $0.18B | $-0.08B | -44.44% |
| 2021-09-30 | $0.16B | $-0.08B | -46.91% |
| 2021-06-30 | $0.15B | $-0.07B | -45.33% |
| 2021-03-31 | $0.12B | $-0.06B | -52.94% |
| 2020-12-31 | $0.11B | $-0.06B | -49.55% |
| 2020-09-30 | $0.09B | $-0.07B | -77.91% |
| 2020-06-30 | $0.05B | $-0.08B | -159.62% |
| 2020-03-31 | $0.04B | $-0.08B | -215.79% |
| 2019-12-31 | $0.01B | $-0.08B | -615.38% |
| 2019-09-30 | $0.00B | $-0.07B | -2233.33% |
| 2019-06-30 | $0.00B | $-0.05B | -2500.00% |
| 2019-03-31 | $0.00B | $-0.04B | -4000.00% |
| 2018-06-30 | $0.00B | $-0.02B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.412B | $0.366B |
| Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.723B | 19.61 |
| Inspire Medical Systems (INSP) | United States | $7.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.477B | 0.00 |
| 10x Genomics (TXG) | United States | $3.208B | 0.00 |
| Enovis (ENOV) | United States | $3.038B | 23.08 |
| Azenta (AZTA) | United States | $2.905B | 236.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.820B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.680B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 94.89 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| Omnicell (OMCL) | United States | $1.248B | 30.53 |
| Phreesia (PHR) | United States | $1.185B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.821B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.680B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.619B | 0.00 |
| Talkspace (TALK) | United States | $0.536B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.373B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.183B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.164B | 0.00 |
| American Well (AMWL) | United States | $0.154B | 0.00 |
| Outset Medical (OM) | United States | $0.147B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
| Augmedix (AUGX) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.04 |
| 111 (YI) | China | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.048B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |